Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia.

Garry, E M

Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. [electronic resource] - Molecular and cellular neurosciences Dec 2005 - 523-37 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1044-7431

10.1016/j.mcn.2005.08.016 doi


Animals
Disease Models, Animal
Enzyme Activation--drug effects
Enzyme Inhibitors--pharmacology
Inflammation Mediators--pharmacology
MAP Kinase Signaling System--drug effects
Male
Mitogen-Activated Protein Kinase 1--drug effects
Neuralgia--metabolism
Neuroglia--drug effects
Neuroprotective Agents--pharmacology
Peripheral Nerve Injuries
Peripheral Nerves--metabolism
Peripheral Nervous System Diseases--metabolism
Phosphorylation--drug effects
Physical Stimulation
Posterior Horn Cells--drug effects
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate--drug effects
Receptors, Neurokinin-2--drug effects
Receptors, Vasoactive Intestinal Peptide, Type II--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Xanthines--pharmacology
p38 Mitogen-Activated Protein Kinases--drug effects